NEWS - Apr 29, 2021 Relmada Therapeutics Announces Poster Presentations at the 2021 Society of Biological Psychiatry Annual Meeting Read more
NEWS - Apr 28, 2021 Relmada Therapeutics Announces Participation in the 7th Annual Truist Securities Life Sciences Summit Read more
NEWS - Apr 27, 2021 Relmada Therapeutics Announces Poster Presentation at the American Society for Pharmacology and Experimental Therapeutics Annual Meeting at Experimental Biology 2021 Read more
NEWS - Apr 1, 2021 Relmada Therapeutics Announces Initiation of Second Pivotal Phase 3 Study of REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder Read more
NEWS - Mar 23, 2021 Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results Read more
NEWS - Mar 18, 2021 Relmada Therapeutics to Report Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on March 23, 2021 Read more
NEWS - Mar 11, 2021 Relmada Therapeutics Announces Participation in the Oppenheimer 31st Annual Healthcare Conference Read more
NEWS - Feb 23, 2021 Relmada Therapeutics Announces Participation in the 2021 SVB Leerink Global Healthcare Conference Read more
NEWS - Dec 7, 2020 Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder Read more
